Atropine Sulfate Injection, Solution
NDC Package 64253-400-91
Package Information
Atropine Sulfate (atropine sulfate injection) injection is a medication used before eye examinations (e.g., refraction) and to treat certain eye conditions (e.g., uveitis). This formulation utilizes a injection, solution delivery system. Marketed by Medefil, Inc., this product is identified by NDC 64253-400 and is authorized under FDA application ANDA214970.
Identification & Billing
- RxCUI: 1190546 - atropine sulfate 1 MG in 10 ML Prefilled Syringe
- RxCUI: 1190546 - 10 ML atropine sulfate 0.1 MG/ML Prefilled Syringe
- RxCUI: 1190546 - atropine sulfate 1 MG per 10 ML Prefilled Syringe
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 64253 - Medefil, Inc.
- 64253-400 - Atropine Sulfate
- 64253-400-91 - 10 SYRINGE, PLASTIC in 1 BOX / 10 mL in 1 SYRINGE, PLASTIC (64253-400-30)
- 64253-400 - Atropine Sulfate
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 64253-400-91 identifies a specific commercial package of 10 syringe, plastic in 1 box / 10 ml in 1 syringe, plastic (64253-400-30) of Atropine Sulfate, a human prescription drug labeled by Medefil, Inc.. This injection, solution is formulated for intravenous use and contains atropine sulfate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Medefil, Inc. on May 11, 2023. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is used before eye examinations (e.g., refraction) and to treat certain eye conditions (e.g., uveitis). It belongs to a class of drugs known as anticholinergics. Atropine works by widening (dilating) the pupil of the eye.
How is this Medefil, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 64253040091. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.